<DOC>
	<DOCNO>NCT02094716</DOCNO>
	<brief_summary>To determine compare safety efficacy PF-045 PF-055 vehicle subject scabies . It anticipate majority subject require receive single treatment ; however , subject show improvement follow-up visit 2 week initial treatment treat second time . Those subject originally assign vehicle first treatment receive `` re-treatment '' one active dos .</brief_summary>
	<brief_title>A Dose Ranging Vehicle Controlled Study Determine Safety Efficacy PF-045 PF-055 Treatment Scabies</brief_title>
	<detailed_description />
	<mesh_term>Scabies</mesh_term>
	<criteria>Clinical diagnosis active scabies infection . Subject good general health normal appear skin noninfested area . Females must postmenopausal , surgically sterile use effective method birth control negative pregnancy test ( 10 year age old ) study start . Subject pregnant , lactating , plan become pregnant study . Subject use ectoparasiticide within three week prior study start . Subject sign systemic infection receive systemic therapy infectious disease . Subject severe cutaneous bacterial fungal infection require therapy heavily crust lesion consistent Norwegian scabies . Subject currently enrol investigational drug device study use investigational drug device within 30 day prior study start . Subject whose close personal contact comply standard care fomite management .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Sarcoptes</keyword>
	<keyword>Scabiei</keyword>
	<keyword>Scabies</keyword>
	<keyword>ectoparasite</keyword>
	<keyword>parasite</keyword>
	<keyword>infestation</keyword>
	<keyword>Renaissance</keyword>
</DOC>